使用TREM1和TSPO PET示踪剂追踪帕金森病小鼠模型中的先天免疫激活
研究在6-羟基多巴胺小鼠帕金森病模型中比较TSPO示踪剂18F-GE-180与TREM1示踪剂64Cu-TREM1单克隆抗体的PET显像效果。两种示踪剂在损伤侧纹状体均显示信号升高,18F-GE-180可检测脑及外周组织炎症,64Cu-TREM1单抗对神经炎症尤其浸润髓系细胞检测更敏感特异。作者认为两者是有前景的工具,需在更多帕金森病动物模型和人类尸检组织中进一步研究以评估临床潜力。
要点
- 在6-羟基多巴胺小鼠模型中,18F-GE-180和64Cu-TREM1示踪剂PET信号在损伤侧纹状体均较生理盐水组升高。
- 64Cu-TREM1单抗对检测神经炎症尤其浸润髓系细胞比18F-GE-180更敏感特异,脑内信号-本底比更高。
- 作者认为TSPO与TREM1 PET示踪剂是有前景的工具,需在更多帕金森病动物模型和人类尸检组织中进一步研究。
核心结论
- TSPO和TREM1 PET示踪剂是研究多巴胺能神经元变性背景下先天免疫激活中不同细胞类型的有前景工具,值得在其他帕金森病动物模型和人类尸检组织中进一步研究以评估其临床潜力。
研究设计与样本
- C57/BL6J小鼠和TREM1基因敲除小鼠左侧纹状体立体定向注射6-羟基多巴胺,对照组注射生理盐水。
- 术后第7天或第14天给予18F-GE-180、64Cu-TREM1单克隆抗体或64Cu同型对照单克隆抗体并行PET/CT显像。
- 进行离体放射自显影获取脑内示踪剂结合的高分辨率图像,并行免疫组化验证髓系细胞激活和多巴胺能细胞死亡,用定量聚合酶链反应和流式细胞术评估脑内靶点水平。
主要发现
- 两种示踪剂的PET/CT图像均显示6-羟基多巴胺注射小鼠纹状体信号较生理盐水注射小鼠升高。
- 放射自显影显示6-羟基多巴胺小鼠损伤同侧纹状体在毒素注射后第7天和第14天TSPO和TREM1示踪剂结合均较生理盐水小鼠显著增高。
- 18F-GE-180可检测6-羟基多巴胺小鼠脑及外周组织(血液和脾)的炎症。
- 64Cu-TREM1单抗对检测这些小鼠的神经炎症尤其浸润髓系细胞显得更敏感和特异,流式细胞术结果和脑内更高的示踪剂结合信号-本底比支持这一点。
局限性
- 作者在结论中指出需在其他帕金森病动物模型和人类尸检组织中进一步研究以评估其临床潜力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Parkinson's disease (PD) is associated with aberrant innate immune responses, including microglial activation and infiltration of peripheral myeloid cells into the central nervous system (CNS). Methods to investigate innate immune activation in PD are limited and have not yet elucidated key interactions between neuroinflammation and peripheral inflammation. Translocator protein 18 kDa (TSPO) PET is a widely evaluated imaging approach for studying activated microglia and peripheral myeloid lineage cells in vivo but has yet to be fully explored in PD. Here, we investigate the utility of TSPO PET in addition to PET imaging of triggering receptor expressed on myeloid cells 1 (TREM1)-a novel biomarker of proinflammatory innate immune cells-for detecting innate immune responses in the 6-hydroxydopamine mouse model of dopaminergic neuron degeneration. Methods: C57/BL6J and TREM1 knockout mice were stereotactically injected with 6-hydroxydopamine in the left striatum; control mice were injected with saline. At day 7 or 14 after surgery, mice were administered 18F-GE-180, 64Cu-TREM1 monoclonal antibody (mAb), or 64Cu-isotype control mAb and imaged by PET/CT. Ex vivo autoradiography was performed to obtain high-resolution images of tracer binding within the brain. Immunohistochemistry was conducted to verify myeloid cell activation and dopaminergic cell death, and quantitative polymerase chain reaction and flow cytometry were completed to assess levels of target in the brain. Results: PET/CT images of both tracers showed elevated signal within the striatum of 6-hydroxydopamine-injected mice compared with those injected with saline. Autoradiography afforded higher-resolution brain images and revealed significant TSPO and TREM1 tracer binding within the ipsilateral striatum of 6-hydroxydopamine mice compared with saline mice at both 7 and 14 d after toxin. Interestingly, 18F-GE-180 enabled detection of inflammation in the brain and peripheral tissues (blood and spleen) of 6-hydroxydopamine mice, whereas 64Cu-TREM1 mAb appeared to be more sensitive and specific for detecting neuroinflammation, in particular infiltrating myeloid cells, in these mice, as demonstrated by flow cytometry findings and higher tracer binding signal-to-background ratios in brain. Conclusion: TSPO and TREM1 PET tracers are promising tools for investigating different cell types involved in innate immune activation in the context of dopaminergic neurodegeneration, thus warranting further investigation in other PD rodent models and human postmortem tissue to assess their clinical potential.
引用
- Lucot KL, Stevens MY, Bonham TA, et al. Tracking Innate Immune Activation in a Mouse Model of Parkinson's Disease Using TREM1 and TSPO PET Tracers. J Nucl Med. 2022. PMID: 35177426. doi:10.2967/jnumed.121.263039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。